{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-026385","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2025-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.162368+00:00","generated_at":"2026-05-16T14:16:31.323958+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Co-Diagnostics shareholders approve reverse stock split up to 1-for-30","bullets":["Special meeting on Dec 5, 2025 approved amendment for reverse stock split.","Vote: 26,465,960 for, 4,213,378 against, 194,746 abstain – passed.","Board authorized to set final ratio between 1-for-2 and 1-for-30 within 12 months.","No other proposals were voted on at the special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-026385","json":"https://secwatch.observer/filing/0001493152-25-026385.json","markdown":"https://secwatch.observer/filing/0001493152-25-026385.md","text":"https://secwatch.observer/filing/0001493152-25-026385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315225026385/0001493152-25-026385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315225026385/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:16:31.323958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}